Researcher Next
Create account
← Back to directory

Óscar Arrieta

Researcher Next ID · RN-010682

Researcher · Medicine

Instituto Nacional de Cancerología

, Colombia

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
813
Citation count
26,249
H-index
61
i10-index
274

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Lung Cancer Diagnosis and Treatment
Cancer Immunotherapy and Biomarkers
Cancer Genomics and Diagnostics

Publications

  • Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

    Journal of Clinical Oncology · 2021 · 10.1200/jco.20.01605

  • Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

    Annals of Oncology · 2018 · 10.1093/annonc/mdy041

  • Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)

    Journal of Clinical Oncology · 2017 · 10.1200/jco.2017.74.3062

  • Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2015 · 10.1056/nejmoa1507643

  • Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

    The Lancet · 2014 · 10.1016/s0140-6736(14)60845-x

Current projects

    No projects listed.